الإحصائيات الأساسية
| CIK | 1601280 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to MediXall Group, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: June 30, 2025 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Repor |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, Inc. |
|
| May 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, Inc. |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: March 31, 2025 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Repo |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2025 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction (C |
|
| April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ü Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: December 31, 2024 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q F |
|
| January 27, 2025 |
Exhibit 19.1 MEDIXALL GROUP INC. INSIDER TRADING COMPLIANCE PROGRAM In order to take an active role in the prevention of insider trading violations by its officers, directors, employees and other related individuals, MediXall Group, Inc. (the “Company”) has adopted the following policies and procedures: I. Adoption of Insider Trading Policy The Company has adopted the Insider Trading Policy attach |
|
| January 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 333-194337 MediXall Group, Inc. (Exact name of registrant as specified |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: September 30, 2024 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition |
|
| August 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: June 30, 2024 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Repor |
|
| June 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, Inc. |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, Inc. |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ü Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: December 31, 2023 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q F |
|
| December 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2023 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction |
|
| December 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2023 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K ü Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: September 30, 2023 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q |
|
| October 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2023 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K ü Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: June 30, 2023 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q For t |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, Inc. (Exa |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2023 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction (Co |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K ü Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: March 31, 2023 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q For |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): X Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: December 31, 2022 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q F |
|
| January 18, 2023 |
MediXall Group Inc. Acquisition Agreement EXHIBIT 10.2 |
|
| January 18, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction |
|
| January 18, 2023 |
MediXall Group Inc. Amendment to Acquisition Agreement EXHIBIT 10.3 |
|
| January 18, 2023 |
MediXall Group Inc. Joint Venture Agreement EXHIBIT 10.1 |
|
| December 30, 2022 |
EXHIBIT 99.1 Richard J. Paull 2344 NE 12th Street Unit E Pompano Beach, FL 33062 561-818-7180 December 14, 2022 MediXall Group, Inc. 2929 E. Commercial Blvd Ph-D Fort Lauderdale, FL 33308 To Whom it May Concern: This letter will serve as my letter of resignation as CFO of MediXall Group, Inc. effective as of today, December 14, 2022. |
|
| December 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 8-K ??????? CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2022 ??????? MediXall Group, Inc. (Exact name of registrant as specified in its charter) ??????? Nevada 333-186282 33-0864127 (State or Other Jurisdiction |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 Medi |
|
| September 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2022 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdictio |
|
| September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2022 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction ( |
|
| August 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 MediXall |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K ? Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: June 30, 2022 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q For t |
|
| August 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 MediXall |
|
| June 21, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2022 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction (Co |
|
| June 21, 2022 |
EXHIBIT 99.1 Dear MediXall Group, Inc. Shareholders. As I assume the role as Chairman of MediXall Group, Inc. (MDXL), I want to take a few moments and reflect on the MDXL vision and our prospects for the future. I also wish to express my appreciation to all MDXL shareholders as well as the management team and employees of MDXL/Health Karma that have helped to ignite our continued passion to improv |
|
| June 15, 2022 |
Stakeholder Letter from Neil Swartz EXHIBIT 99.1 Stakeholder Letter from Neil Swartz Dear stakeholder, What amazing times we are in ? challenging and rewarding. I?m sure many of you are watching the news and wondering how to keep moving forward and building for the future with so many preaching gloom and doom. Perhaps you?re having a few anxious moments as you contemplate how to manage and figure out what your next moves should be. |
|
| June 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2022 ——————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ——————— Nevada 333-186282 33-0864127 (State or Other Jurisdiction (Co |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NT 10-Q 1 mdxl12b25.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K ü Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: March 31, 2022 Transition Report on Form 10-K Transition Report on Form 20-F Transition Rep |
|
| April 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, Inc. (Exa |
|
| March 31, 2022 |
NT 10-K 1 mdxl12b25.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): X Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: December 31, 2021 Transition Report on Form 10-K Transition Report on Form 20-F Transition |
|
| November 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 Medi |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K ü Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: September 30, 2021 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q |
|
| October 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: |
|
| September 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 MediXall |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NT 10-Q 1 mdxl12b25.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K X Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: June 30, 2021 Transition Report on Form 10-K Transition Report on Form 20-F Transition Repo |
|
| August 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdxl10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commiss |
|
| June 17, 2021 |
10-K 1 mdxl10k.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333 |
|
| March 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): X Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: December 31, 2020 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q T |
|
| January 29, 2021 |
Quarterly Report - AMENDED QUARTERLY REPORT Amended Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdxl10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Com |
|
| November 17, 2020 |
EX-10.1 2 mdxlex10z1.htm CONSULTING AGREEMENT EXHIBIT 10.1 CONSULTING AGREEMENT This Consulting Agreement (the “Agreement”) is made as of July 1, 2019 (the “Effective Date”) by and between MediXall Group, Inc., a corporation organized under the laws of the State of Nevada, with its principal place of business at 2929 E. Commercial Blvd., PH-D, Ft. Lauderdale, FL 33308, (the “Company”), and TBG Hol |
|
| November 13, 2020 |
NT 10-Q 1 mdxl12b25.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K X Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: September 30, 2020 Transition Report on Form 10-K Transition Report on Form 20-F Transition |
|
| September 29, 2020 |
S-1/A 1 mdxls1.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on September 29, 2020 Registration No. 333-234514 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 2 TO Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MediXall Group, Inc. (Exact name of registrant as specified in its charter) Nevada 80 |
|
| September 3, 2020 |
S-1/A 1 mdxls1.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on September 3, 2020 Registration No. 333-234514 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MediXall Group, Inc. (Exact name of registrant as specified in its charter) Nevada 809 |
|
| September 3, 2020 |
EX-21.1 3 mdxlex21z1.htm SUBSIDIARIES Exhibit 21.1 SUBSIDIARIES The Company has the following wholly-owned subsidiaries: Company Jurisdiction of Incorporation or Organization Status MediXall.com, Inc. Florida Active Medixall Financial Group, Inc. Florida Dormant IHL of Florida, Inc. Florida Dormant Health Karma, Inc. Florida Active Medixaid, Inc. Florida Active |
|
| August 14, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 MediXall |
|
| July 29, 2020 |
Definitive Acquisition Agreement EX-10.1 2 mdxlex10z1.htm DEFINITIVE ACQUISITION AGREEMENT EXHIBIT 10.1 DEFINITIVE ACQUISITION AGREEMENT In consideration of the mutual promises, covenants, and representations contained herein, The Effective Closing Date of this Definitive Agreement shall be July 27, 2020, between MediXall Group, Inc., a Nevada corporation with its offices located at 2929 East Commercial Boulevard, PH-D, Fort Laud |
|
| July 29, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 mdxl8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————— FORM 8-K ————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2020 ————— MediXall Group, Inc. (Exact name of registrant as specified in its charter) ————— Nevada 333-194337 33-0864127 (State or Othe |
|
| June 24, 2020 |
8-K 1 mdxl8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2020 MEDIXALL GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 333-194337 33-0864127 (State of Incorporation) (Commission F |
|
| June 24, 2020 |
Certificate of Designation of Series B Preferred Stock Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE PREFERRED STOCK of MediXall Group, Inc. a Nevada corporation Pursuant to Section 78.1955 of the Nevada Revised Statutes The undersigned, Neil Schwartz, hereby certifies that: 1. He is the duly elected Interim Chief Executive Officer of MediXall Group, Inc. a Nevada corporation (“Corporation”). 2. A resolution |
|
| June 16, 2020 |
Quarterly Report - QUARTERLY REPORT 10-Q 1 mdxl10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commiss |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, Inc. (Exa |
|
| May 14, 2020 |
8-K 1 mdxl8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest reported): May 14, 2020 MediXall Group, Inc. (Exact name of registrant as specified in its charter) Nevada 333-194337 33-0864127 (State or other jurisdiction (Commission |
|
| March 30, 2020 |
MDXL / MediXall Group, Inc. NT 10-K - - NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 14, 2019 |
MDXL / MediXall Group, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT 10-Q 1 mdxl10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Com |
|
| November 5, 2019 |
EX-21.1 3 mdxlex21z1.htm SUBSIDIARIES Exhibit 21.1 SUBSIDIARIES Company Jurisdiction of Incorporation or Organization MediXall.com, Inc. Florida Medixall Financial Group, Inc. Florida |
|
| November 5, 2019 |
MDXL / MediXall Group, Inc. S-1 - Registration Statement - REGISTRATION STATEMENT Registration Statement As filed with the Securities and Exchange Commission on November 5, 2019 Registration No. |
|
| August 2, 2019 |
MDXL / MediXall Group, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333 |
|
| May 30, 2019 |
MDXL / MediXall Group, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 33 |
|
| May 16, 2019 |
MDXL / MediXall Group, Inc. 10-K Annual Report ANNUAL REPORT Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Gr |
|
| May 15, 2019 |
MDXL / MediXall Group, Inc. NT 10-Q NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 29, 2019 |
MDXL / MediXall Group, Inc. NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 14, 2018 |
MDXL / MediXall Group, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| August 14, 2018 |
MDXL / MediXall Group, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333 |
|
| June 29, 2018 |
MDXL / MediXall Group, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 33 |
|
| June 4, 2018 |
Changes in Registrant's Certifying Accountant 8-K 1 mdxl8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2018 MediXall Group, Inc. (Exact name of registrant as specified in its charter) Nevada 333-194337 33-0864127 (State or Other Jurisdiction (Com |
|
| May 10, 2018 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2018 MediXall Group, Inc. (Exact name of registrant as specified in its charter) Nevada 333-194337 33-0864127 (State or Other Jurisdiction (Commission (I.R.S. Em |
|
| March 30, 2018 |
MDXL / MediXall Group, Inc. AMENDED ANNUAL REPORT (Annual Report) Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall |
|
| March 8, 2018 |
Letter from Baum & Company, P.A. EX-16.1 2 mdxlex16z1.htm AUDITOR LETTER EXHIBIT 16.1 Baum & Company, P.A. 1688 Meridian Avenue Suite 504 Miami Beach, FL 33139 March 7, 2018 Securities and Exchange Commission 100 F Street Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of MediXall Group, Inc. Form 8-K dated March 7, 2018, and in agreement with the statements relating to Baum & Company, Inc. contained therein. |
|
| March 8, 2018 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2018 MediXall Group, Inc. (Exact name of registrant as specified in its charter) Nevada 333-194337 33-0864127 (State or Other Jurisdiction (Commission (I.R.S. |
|
| March 5, 2018 |
MDXL / MediXall Group, Inc. AMENDED ANNUAL REPORT (Annual Report) Amended Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 1, 2018 |
MDXL / MediXall Group, Inc. ANNUAL REPORT (Annual Report) Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Gr |
|
| November 20, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| November 14, 2017 |
CRCX / Continental Rail Corp. NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 21, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333 |
|
| August 14, 2017 |
Continental Rail NOTIFICATION OF LATE FILING NT 10-Q 1 mdxl12b25.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-194337 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K X Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: June 30, 2017 Transition Report on Form 10-K Transition Report on Form 20-F Transition Repo |
|
| May 22, 2017 |
Continental Rail QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 33 |
|
| May 22, 2017 |
Continental Rail AMENDED ANNUAL REPORT (Annual Report) Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall |
|
| May 15, 2017 |
Continental Rail NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 30, 2017 |
Continental Rail ANNUAL REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 MediXall Group, Inc. (Exa |
|
| January 4, 2017 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ???????? FORM 8-K ???????? CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2017 MediXall Group, Inc. (Exact name of registrant as specified in its charter) ???????? Nevada 333-194337 33-0864127 (State or Other Juri |
|
| January 3, 2017 |
Continental Rail CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ???????? FORM 8-K ???????? CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2016 MediXall Group, Inc. (Exact name of registrant as specified in its charter) ???????? Nevada 333-194337 33-0864127 (State or Other Ju |
|
| December 16, 2016 |
Continental Rail CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ???????? FORM 8-K ???????? CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2016 MediXall Group, Inc. (Exact name of registrant as specified in its charter) ???????? Nevada 333-194337 33-0864127 (State or Other Ju |
|
| December 16, 2016 |
Exhibit 99.1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of MediXall, Inc. We have audited the accompanying balance sheet of MediXall, Inc. (the ?Company?) as of December 31, 2015 and the related statements of operations, changes in stockholders? equity, and cash flows for the period November 24, 2015 (date of inception) through December 31, 2 |
|
| December 16, 2016 |
Exhibit 99.2 IHL OF FLORIDA, INC. AND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) CONDENSED CONSOLIDATED BALANCE SHEET SEPTEMBER 30, 2016 (UNAUDITED) ASSETS CURRENT ASSETS: Cash $ 42,956 Advances receivable - related parties 86,442 Total Current Assets 129,398 Total Assets $ 129,398 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES: Accounts payable - related party $ 4,957 Accrued expenses 12 |
|
| December 16, 2016 |
Share Exchange Agreement and Plan of Reorganization EX-10.1 2 mdxlex10z1.htm SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION Exhibit 10.1 SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION This SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION (this “Agreement”) is entered into as of this 13th day of December 2016 by and among, MediXall Group, Inc., a Nevada corporation (“MDXL”), and IHL of Florida, Inc., a Florida corporation (“MEDIX”). REC |
|
| December 16, 2016 |
Exhibit 10.2 EXHIBIT 10.2 |
|
| December 16, 2016 |
EX-99.3 6 mdxlex99z3.htm UNAUDITED PRO FORMA FINANCIAL INFORMATION Exhibit 99.3 MEDIXALL GROUP, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2016 AND THE YEAR ENDED 2015 Description of Pro Forma Transactions IHL of Florida, Inc. Acquisition On December 13, 2016, MediXall Group, Inc., a Nevada corporation (“MDXL”), formerly known as Co |
|
| November 16, 2016 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment EXHIBIT 3.1 |
|
| November 16, 2016 |
EX-3.2 3 crcxex3z2.htm CERTIFICATE OF CORRECTION EXHIBIT 3.2 |
|
| November 16, 2016 |
Continental Rail CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2016 Continental Rail Corp. (Exact name of registrant as specified in its charter) Nevada 333-194337 33-0864127 (State or Other Jurisdiction (Commission (I. |
|
| November 16, 2016 |
EX-3.3 4 crcxex3z3.htm CERTIFICATE OF CHANGE EXHIBIT 3.3 |
|
| November 4, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2016 Continental Rail Corp. (Exact name of registrant as specified in its charter) Nevada 333-194337 33-0864127 (State or Other Jurisdiction (Commission (I. |
|
| November 4, 2016 |
Continental Rail QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| August 12, 2016 |
Continental Rail QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333 |
|
| June 27, 2016 |
EX-10.1 2 crcxex10z1.htm AGREEMENT EXHIBIT 10.1 DEFINITIVE AGREEMENT FOR THE EXCHANGE OF COMMON STOCK FOR LIMITED LIABILITY COMPANY INTEREST In consideration of the mutual promises, covenants, and representations contained herein, The Effective Closing Date of this Definitive Agreement dated this 24th day of June, 2016 between TBG Holdings Corporation, a Florida corporation (hereinafter referred t |
|
| June 27, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2016 Continental Rail Corp. (Exact name of registrant as specified in its charter) Nevada 333-194337 33-0864127 (State or Other Jurisdiction (Commission (I.R.S |
|
| May 16, 2016 |
Continental Rail QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 Continen |
|
| April 28, 2016 |
Continental Rail ANNUAL REPORT (Annual Report) Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 Continental |
|
| March 30, 2016 |
Continental Rail NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 Cont |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333 |
|
| June 26, 2015 |
Agreement EXHIBIT 10.1 AGREEMENT This is an Agreement made as of this 19 day of June, 2015 by and between Continental Rail Corp. (Continental or Corporation), a Nevada corporation with its principal place of business at 2929 E. Commercial Boulevard, PH-D, Fort Lauderdale, FL 33308, Continental Rail, LLC (LLC), a Florida limited liability company with its principal place of business at 2929 E |
|
| June 26, 2015 |
Continental Rail CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2015 Continental Rail Corp. (Exact name of registrant as specified in its charter) Nevada 333-194337 33-0864127 (State or Other Jurisdiction (Commission (I.R.S |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 Continen |
|
| April 30, 2015 |
Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-194337 Continental |
|
| March 31, 2015 |
Continental Rail NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 30, 2015 |
CONTINENTAL RAIL CORP. 7,219,688 Shares of Common Stock PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3) Registration No. 333-194337 PROSPECTUS SUPPLEMENT NO. 1, DATED MARCH 25, 2015 (to prospectus dated October 16, 2014) CONTINENTAL RAIL CORP. 7,219,688 Shares of Common Stock This Prospectus Supplement No. 1 supplements information contained in the prospectus dated October 16, 2014 relating to the resale by selling stockholders of Continental Ra |
|
| December 16, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 Co |
|
| December 1, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194337 Cont |
|
| October 22, 2014 |
PROSPECTUS CONTINENTAL RAIL CORP. 7,219,688 Shares of Common Stock 424B3 1 crcx424b.htm PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-194337 PROSPECTUS CONTINENTAL RAIL CORP. 7,219,688 Shares of Common Stock This prospectus relates to periodic offers and sales of 7,219,688 shares of our common stock by the selling stockholders, including 1,855,052 shares owned by our executive officers, directors and their affiliates. We will not receive any pr |
|
| October 14, 2014 |
MDXL / MediXall Group, Inc. CORRESP - - CORRESP 1 filename1.htm Continental Rail Corp. 2929 East Commercial Boulevard, PH-D Fort Lauderdale, FL 33308 Telephone (954) 440-4678 October 14, 2014 ‘CORRESP’ Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Continental Rail Corp. (the “Company”) Registration Statement on Form S-1 File No. 333-194337 Ladies and Gentle |
|
| October 2, 2014 |
MDXL / MediXall Group, Inc. CORRESP - - Response Letter Continental Rail Corp. 2929 East Commercial Boulevard, PH-D Fort Lauderdale, FL 33308 Telephone (954) 440-4678 October 1, 2014 ‘CORRESP’ Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Donald E. Field Linda Cvrkel, Accounting Branch Chief Effie Simpson Re: Contine |
|
| October 2, 2014 |
MDXL / MediXall Group, Inc. S-1/A - - REGISTRATION STATEMENT S-1/A 1 crcxs1a.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on October 2, 2014 Registration No. 333-194337 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO THE FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Continental Rail Corp. (Exact name of registrant as specified in its charter) Nevada (State or ot |
|
| September 12, 2014 |
MDXL / MediXall Group, Inc. S-1/A - - REGISTRATION STATEMENT Registration Statement As filed with the Securities and Exchange Commission on September 12, 2014 Registration No. |
|
| September 12, 2014 |
MDXL / MediXall Group, Inc. CORRESP - - Response Letter Continental Rail Corp. 2929 East Commercial Boulevard, PH-D Fort Lauderdale, FL 33308 Telephone (954) 440-4678 September 11, 2014 ‘CORRESP’ Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Donald E. Field Linda Cvrkel, Accounting Branch Chief Effie Simpson Re: Cont |
|
| July 15, 2014 |
EX-10.2 5 crcxex10z2.htm LETTER AGREEMENT EXHIBIT 10.2 |
|
| July 15, 2014 |
EX-10.4 6 crcxex10z4.htm EMPLOYMENT AGREEMENT EXHIBIT 10.4 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement") is made effective as of February 15, 2013 (the “Effective Date”), by and between IGSM Group Inc. or successor company (”IGSM” or “the Company”), of East 2929 Commercial Blvd, Suite PH-D, Fort Lauderdale, Florida, 33308 and John Marino JR.(“Executive” or “Employee”) of IGSM i |
|
| July 15, 2014 |
MDXL / MediXall Group, Inc. S-1/A - - REGISTRATION STATEMENT Registration Statement As filed with the Securities and Exchange Commission on July 15, 2014 Registration No. |
|
| July 15, 2014 |
Amendment to Independent Consultant Agreement AMENDMENT TO INDEPENDENT CONSULTANT AGREEMENT EXHIBIT 10.7 AMENDMENT TO INDEPENDENT CONSULTANT AGREEMENT THIS AMENDMENT TO INDEPENDENT CONSULTANT AGREEMENT is made this 24th day of June, 2014, effective October 2, 2013 (the “Effective Date”), by and between CONTINENTAL RAIL CORP., a Nevada corporation (the “Company”), and JOHN M. KEASLING, an individual (the “Consultant”). R E C I T A L S WHEREAS, |
|
| July 15, 2014 |
EX-10.5 7 crcxex10z5.htm AMENDMENT NO. 1 TO AGREEMENT Exhibit 10.5 AMENDMENT NO. 1 TO AGREEMENT THIS AMENDMENT NO. 1 TO AGREEMENT is made as of the 25th day of June, 2013, by and among ISGM Group, Inc., a Nevada corporation (“ISGM”), TBG Holdings Corporation, a Florida corporation (“TBG”), Neil Swartz, Tim Hart, Larry Coe and John Marino Sr. (collectively, the “Management Team”), Transportation Ma |
|
| July 15, 2014 |
MDXL / MediXall Group, Inc. CORRESP - - Response Letter Continental Rail Corp. 2929 East Commercial Boulevard, PH-D Fort Lauderdale, FL 33308 Telephone (954) 440-4678 July 15, 2014 ‘CORRESP’ Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Donald E. Field Linda Cvrkel, Accounting Branch Chief Effie Simpson Re: Continent |
|
| July 15, 2014 |
Amended and Restated Articles of Incorporation Amended and Restated Articles of Incorporation EXHIBIT 3.16 |
|
| July 15, 2014 |
Independent Consultant Agreement EX-10.6 8 crcxex10z6.htm INDEPENDENT CONSULTANT AGREEMENT EXHIBIT 10.6 |
|
| July 15, 2014 |
EXHIBIT 10.1 |
|
| March 5, 2014 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.7 |
|
| March 5, 2014 |
Certificates of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.5 |
|
| March 5, 2014 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.9 |
|
| March 5, 2014 |
Certificates of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.6 |
|
| March 5, 2014 |
Articles of Merger EXHIBIT 3.2 |
|
| March 5, 2014 |
Letter agreement EXHIBIT 10.2 |
|
| March 5, 2014 |
Articles of Incorporation EXHIBIT 3.1 |
|
| March 5, 2014 |
Code of Business Conduct and Ethics CODE OF BUSINESS CONDUCT AND ETHICS EXHIBIT 14.1 CONTINENTAL RAIL CORP. CODE OF BUSINESS CONDUCT AND ETHICS (Adopted by the Board of Directors on February 26, 2014) Introduction This Code of Business Conduct and Ethics covers a wide range of business practices and procedures. It does not cover every issue that may arise, but it sets out basic principles to guide all officers, directors and employe |
|
| March 5, 2014 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.13 |
|
| March 5, 2014 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.8 |
|
| March 5, 2014 |
EMPLOYMENT AGREEMENT EXHIBIT 10.4 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement") is made effective as of February 15, 2013 (the “Effective Date”), by and between IGSM Group Inc. or successor company (”IGSM” or “the Company”), of East 2929 Commercial Blvd, Suite PH-D, Fort Lauderdale, Florida, 33308 and John Marino JR.(“Executive” or “Employee”) of IGSM is engaged in the business |
|
| March 5, 2014 |
Bylaws EXHIBIT 3.15 |
|
| March 5, 2014 |
Agreement EXHIBIT 10.1 |
|
| March 5, 2014 |
Certificates of Amendment to the Articles of Incorporation Certificates of Amendment to the Articles of Incorporation EXHIBIT 3.14 |
|
| March 5, 2014 |
Subsidiaries of the Registrant Subsidiaries of the Registrant EXHIBIT 21.1 Subsidiaries of the Registrant Transportation Management Services, Inc., a Michigan corporation Continental Rail Holdings Corp., a Nevada corporation Continental Rail Leasing Corp., a Florida corporation |
|
| March 5, 2014 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.11 |
|
| March 5, 2014 |
EMPLOYMENT AGREEMENT EXHIBIT 10.3 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement") is made effective as of February 15, 2013 (the “Effective Date”), by and between IGSM Group Inc. or successor company (”IGSM” or “the Company”), of East 2929 Commercial Blvd, Suite PH-D, Fort Lauderdale, Florida, 33308 and Wayne A. August (“Executive” or “Employee”) of. A. IGSM is engaged in the bus |
|
| March 5, 2014 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.4 |
|
| March 5, 2014 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.3 |
|
| March 5, 2014 |
Certificate of Amendment to the Articles of Incorporation Certificate of Amendment to the Articles of Incorporation EXHIBIT 3.10 |
|
| March 5, 2014 |
Registration Statement - REGISTRATION STATEMENT Registration Statement As filed with the Securities and Exchange Commission on March 5, 2014 Registration No. |
|
| March 5, 2014 |
Certificate of Change EXHIBIT 3.12 |
